Introduction: There is insufficient evidence on the efficacy and safety of pharmacological cardioversion of recent-onset atrial fibrillation (AF) in elderly patients. Antazoline has been shown to be ...

Atrial fibrillation (AF), the most common arrhythmia in adults, is associated with significant morbidity, health care utilization, and cost burden. 1 As such, strategies that safely, effectively, and ...

Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to new research. Apixaban lowers the ...

MILAN, ITALY — New research has shed light on a mechanism other than multiple infarcts that may contribute to the association between between atrial fibrillation (AF) and decreased brain function [1].

However, several factors confound the role of inflammation in generation and perpetuation of AF. As an example, failure to show a correlation between baseline hsCRP levels and maintenance of sinus ...

BARCELONA -- Cardiologists who have switched atrial fibrillation patients awaiting elective cardioversion to a novel oral anticoagulant (NOAC) such as rivaroxaban (Xarelto) may find reassurance in the ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

"Due to the risk of thromboembolism, clinical guidelines recommend anticoagulation before and after cardioversion in patients with atrial fibrillation," said Andreas Goette, MD, Chief Physician, St.

Atrial fibrillation (AF or afib) involves abnormal electrical activity in the upper chambers (atria) of your heart, which causes the organ to beat quickly and irregularly. This abnormal beating ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...